PUNE, India, February 10, 2016 /PRNewswire/ --
The "Personalized Medicine, Targeted Therapeutics and Companion
Diagnostic Market to 2019 - Strategic Analysis of Industry Trends,
Technologies, Participants, and Environment" research report
indicates that the core personalized medicine market will be worth
over $149 billion by 2020 growing at
a CAGR of 8.74%. This market is made up of companion diagnostics
and targeted therapeutics and is dominated by oncology,
cardiovascular and infectious disease treatment and
diagnostics.
Complete report on personalized medicine, targeted therapeutics
and companion diagnostic market spread across 393 pages, analyzing
58 major companies and providing 365 tables & figures is now
available at
http://www.reportsnreports.com/reports/472795-personalized-medicine-targeted-therapeutics-and-companion-diagnostic-market-to-2019-strategic-analysis-of-industry-trends-technologies-participants-and-environment.html.
The report forecasts that the total personalized targeted
therapeutic market, for all indications, will grow at a CAGR of
6.47% over the next five years. Strong vertical growth in the
companion diagnostic segment however will see a CAGR of 23.71% to
2020, mainly coming from oncology, cardiovascular and infectious
disease (HIV/HCV) tests. Advancing technologies within the liquid
biopsy market is also driving the market and will see strategic
growth over the next five years with a CAGR of 20.6%. The two
segments of the liquid biopsy market are tumor cell enrichment
products and tumor cell detection technologies.
This report describes the current technologies that are
propelling the personalized medicine and companion diagnostic
market. It examines the current genetic diagnostic tests and
companion diagnostic assays that are in use by the medical and
pharmaceutical industry today. Current developments in personalized
medicine and the pharmacogenomics revolution are discussed. The
emerging trends that appear in key markets such as the US, UK,
Germany and France are elucidated and analyzed. This study
reveals market figures of the overall personalized medicine market
and also sub-market figures. Forecast projections and future growth
rates are provided to give the reader a forthcoming perspective of
this growing industry.
This new report gives a comprehensive account of the market
size, segmentation, key players, SWOT analysis, influential
technologies, and business and economic environments. The
personalized medicine market is presented as follows: By Company
(e.g., QIAGEN, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode
/Amgen, CELERA, MYRIAD); By Segment (Targeted therapeutics,
Companion Diagnostics); By Sub-market (Companion diagnostic,
targeted cancer therapeutic, medical technology, pharmacogenomics,
consumer genomics, molecular diagnostics, liquid biopsy); By
Therapy (Cancer, Cardiovascular, Infectious Disease). Order a copy
of Personalized Medicine, Targeted Therapeutics and Companion
Diagnostic Market to 2019 report @
http://www.reportsnreports.com/purchase.aspx?name=472795.
Companies Mentioned: 23andMe, Abbott Laboratories, Abbott
Molecular Inc., Admera Health (GENEWIZ), Affymetrix,
Agendia, Alere, Amgen, Astex Pharmaceuticals, AstraZeneca, Atossa
Genetics, Becton Dickenson,
bioMerieux, BristolMyersSquibb, Cancer Genetics, Celera (Quest
Diagnostics), Celldex Therapeutics, Claritas Genomics, CuraGen,
Danaher (Leica Biosystems), deCode Genetics (Amgen), Foundation
Medicine, EDP Biotech, Eli Lilly, ELDA BioTech, Eisai, Genelex,
GlaxoSmithKline, Human Longevity Inc (Cypher Genomics), HalioDx,
Ikonisys, Illumina, InterGenetics, Johnson & Johnson, LabCorp,
Life Technologies, Merck, MDxHealth, MolecularMD Corporation,
Monogram Biosciences, Myriad, Nodality, Novartis MDx, Orion
Genomics, Oxford BioTherapeutics, NanoString Technologies, Pfizer,
Qiagen, Roche Molecular Diagnostics, Sanofi, SensiGen, Siemens
Healthcare Diagnostics, Takeda, Thermo Fisher Scientific,
Transgenomic, Ventana (Roche),
Vermillion (Ciphergen) and Vertex Pharmaceuticals.
SWOT, Economic & Regulatory Environment specifics include
the key strengths, weaknesses and threats influencing leading
player position within the market. The report includes the
technologies that drive the market (e.g., New-Generation Sequencing
Technologies, Ultra-High Throughput Sequencing). The report also
includes top fastest growing market segments and emerging
opportunities supported with the top pharmaceutical companies
within the IPM by market share and revenue. The report provides a
comprehensive product portfolios, R&D activity and pipeline
therapeutics. M&A activity and future strategies of top
personalized medicine pharmacos. Personalized Medicine Regulation
(USA, UK, Germany, France, Spain, Italy). CE-marked Personalized
Medicine/Diagnostic Tests and the FDA Advances in Personalized
Medicine Regulation.
Explore other new reports on pharmaceuticals market at
http://www.reportsnreports.com/market-research/pharmaceuticals/
.
About Us:
ReportsnReports.com is an online market research reports library
of 500,000+ in-depth studies of over 5000 micro markets. Not
limited to any one industry, ReportsnReports.com offers research
studies on agriculture, energy and power, chemicals, environment,
medical devices, healthcare, food and beverages, water, advanced
materials and much more.
Connect With Us on:
Facebook: https://www.facebook.com/ReportsnReports/
LinkedIn:
https://www.linkedin.com/company/reportsnreports
Twitter: https://twitter.com/marketsreports
G+ / Google Plus:
https://plus.google.com/111656568937629536321/posts
RSS/Feeds:
http://www.reportsnreports.com/feed/l-latestreports.xml
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com